CELIAC PEOPLE HEALTH CARE WEAKNESSES IN THE UNIFIED HEALTH SYSTEM (SUS): A USER’S PERSPECTIVE
DOI:
https://doi.org/10.12957/demetra.2014.10499Keywords:
Educação em Saúde, Doença Celíaca, Alimentos, Acesso aos serviços de saúde.Abstract
Celiac disease is a multisystem autoimmune disease that can manifest at any age, in genetically predisposed individuals, whose only treatment is based on the adherence to gluten-free diet throughout lifetime. This essay aims to list points and counterpoints on the weaknesses of and in health care to the people with celiac disease in the Brazilian Unified Health System [the so-called SUS), based on the experience reported by system users. The authors are members of the ACELBRA (Association of Celiac People in Brazil) and requests received by this entity served as the basis for this essay. The situations summarized here refer to routine requests for information, and guidance, complaints, questions, produced in-person meetings or materialized during mediation in online forums by the tools of co-help groups during the period 2007-2014, involving about twenty thousand members from different regions of the country. Given the increase in the number of diagnosed cases of celiac disease after the approval of the clinical protocol in 2009, this text is not just a list of complaints, but a map of weaknesses and bottlenecks in a system.
DOI: http://dx.doi.org/10.12957/demetra.2014.10499
Downloads
References
Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med. 2005; 142(4): 289-98.
Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology. 2005;128(4 Suppl 1):S47-S51.
Rewers M, Liu E, Simmons J, Redondo MJ, Hoffenberg EJ. Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2004;33(1):197-214.
Peres AM et al. An electronic tongue for gliadins semi-quantitative detection in foodstuffs. Talanta. 2011 jan;83(3):857-64.
Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128(4 Suppl1):S74-S8.
Galvão LC et al. Apresentação clínica de doença celíaca em crianças durante dois períodos, em serviço universitário especializado. Arq Gastroenterol. 2004 dez; 41(4):234-8.
Kotze, LMS. Celiac disease in Brazilian patients: associations, complications and causes of death. Forty years of clinical experience. Arq. Gastroenterol. [online]. 2009, vol.46, n.4, pp. 261-269.
Sdepanian VL, Morais MBD, Fagundes-Neto U. Doença celíaca: a evolução dos conhecimentos desde sua centenária descrição original até os dias atuais. Arq Gastroenterol. 1999; 36(4):244-57.
AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology. 2006;131(6):1977-80.
Torres MI, Lopez Casado MA, Rios A. New aspects in celiac disease. World J Gastroenterol. 2007;13(8):1156-61.
Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357(17):1731-43.
Fasano A1, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001 Feb;120(3):636-51.
Sapone, A. et AL. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Medicine 2012, 10:13 http://www.biomedcentral.com/1741-7015/10/13.
HIJJAR, M A. et AL. Epidemiologia da tuberculose: importância no mundo, no Brasil e no Rio de Janeiro. Pulmão. Rio de Janeiro. 2005;14(4):310-314.
Brasil. Ministério da Saude. Protocolo Clinico da Doença celiaca. Brasilia-DF 2010.
Brasil. Ministério da Saude, Ministério do Desenvolvimento Social e Combate a fome, Acelbra-SP. Emília e a Turma do Sítio em o que é doença celíaca: conheça a doença celíaca e os cuidados que ela exige. Rio de Janeiro: Editora Globo. 2008. http://www.riosemgluten.com/cartilhadaemilia.pdf>
Fenacelbra Federação Nacional das Associações de Celíacos do Brasil. Guia orientador para celíacos. Elaboração de Almir Correa Moraes et all. - São Paulo: Escola Nacional de Defesa do Consumidor, Ministério da Justiça, 2010. http://www.riosemgluten.com/guiaorientadorparaceliacos2010.pdf>
Burity V. et al. Direito humano à alimentação adequada no contexto da segurança alimentar e nutricional. - Brasília, DF: Abrandh, 2010. 204p.
Crucinsky, J. Dez passos para a alimentação do celíaco: cartilha. Acelbra-RJ, Rio Sem Gluten. Rio de Janeiro. 2012. http://www.riosemgluten.com/10passosceliacosjulianacrucinsky.pdf>
Araújo, H. M. C.; Araújo, W. M. C.; Botelho, R.B.A,; Zandonadi, R. P. Doença celíaca, hábitos e práticas alimentares e qualidade de vida. Rev. Nutr., Campinas, 2010, 23(3):467-474, maio/jun.
Calder, P.C.; Albers, R.; Antoine, J.M.; Blum, S.; Bourdet-Sicard, R.; Ferns, G.A.; Folkerts, G.; Friedmann, P.S.; Frost, G.S.; Guarner, F.; et al. Inflammatory disease processes and interactions with nutrition. Br. J. Nutr. 2009, 101, 1–45.
Hallert C, Grant C, Grehn S, Granno C, Hultén S, Midhagens G, Strom M, Svensson H, Valdimarsson T. Evidence of poor vitamin status in coelic patients on a gluten-free diet for 10 years. Aliment. Pharmacol. Ther. 2002, 16, 1333-1339.
Diamanti A, Capriati T, Basso MS, Panetta F, Di Laurora VM, Bellucci F, Cristofori F, Francavilla R. Celiac disease and overweight in children: an update. Nutrients, 2014, 6, 207-220.
Dickey, W.; Kearney, N. Overweight in celiac disease: Prevalence, ClinicalCharacteristics, and Effect of a Gluten-Free Diet. Am J Gastroenterol 2006;101:2356–2359.
Fasano A: leaky gut and autoimmune disease. Clinic Rev Allerg Immunol, 2011.
Fasano A. Intestinal zonulin: open sesame. Gut 2001;49:159–162.
Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 91: 151–175, 2011.
Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol. 2012 October ; 10(10): 1096–1100.
Ferreti G, Bacchetti T, Masciangelo S, Saturni L. Celiac Disease, Inflammation and Oxidative Damage: A Nutrigenetic Approach. Nutrients 2012, 4, 243-257;
Kristjánsson G, Venge P, Hallgren R. Mucosal reactivity to cow’s milk protein in coeliac disease. Clinical and Experimental Immunology, 147: 449–455, 2007.
Suzuki, T.; Hara, H. Role of flavonoids in intestinal tight junction regulation. J. Nutr. Biochem. 2011, 22, 401–408.
Cordain L, Toohey L, Smith MJ, Hickey MS: Modulation of imune function by dietary lectins in rheumatoid arthritis. Br J Nutr 2000, 83:207-217.
Cabrera-Chavez F, Iametti S, Miriani M, de la Barca AM, Mamone G, Bonomi F. Maize prolamins resistant to peptic-tryptic digestion maintain immune-recognition by iga from some celiac disease patients. Plant Foods Hum Nutr. 2012 Mar;67(1):24, 30.
Paula FA, Benati, R. Torne-se um par para que sua vida seja impar. Acelbra-RJ, Rio Sem Gluten. 2013.
Downloads
Published
How to Cite
Issue
Section
License
STATEMENT OF AUTHORSHIP RESPONSIBILITY
Title of the manuscript:
________________________________________________________
1. Statement of responsability
I certify that I have participated in the work above specified and take public responsibility for its content.
I certify that the manuscript represents an original work and that none of the material in the manuscript has been previously published, is included in another manuscript, or is currently under consideration for publication elsewhere, whether in printed form or in electronic media, except that described in the attachment.
In case of acceptance of this text by Demetra: Alimentação, Nutrição & Saude, I declare to be in accordance with the policy of public access and copyright adopted by Demetra, which provides as follows: (a) the authors retain the copyright and grant to the Journal the right of first publication, the work being simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of the work with acknowledgment of authorship and initial publication in this journal; (b) authors are authorized to enter additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal; and (c) authors are permitted and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this may lead to productive changes, as well as increase the impact and citation of the published work.
2. Conflict of Interest Statement
I certify that there is no conflict of interest in connection with the submitted article.
Date, signature and full address of all authors.